DIPLOMA PLC
10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE
TELEPHONE: +44 (0)20 7549 5700
FACSIMILE: +44 (0)20 7549 5715
22 March 2023
DIPLOMA PLC
(the "Company" and together with its subsidiaries "Diploma" or the "Company")
ISSUE OF SHARES AND TOTAL VOTING RIGHTS
Diploma today announces that it has allotted and issued 3,984 new Ordinary Shares of 5p each in the capital of the Company (the "New Shares"). The New Shares have been allotted and issued to the Diploma PLC Employee Benefit Trust ("EBT").
The EBT now holds a total of 71,415 Ordinary Shares of 5p each in the capital of the Company, representing 0.05 per cent. of the issued share capital.
In relation to the above, applications have been made to the Financial Conduct Authority for admission of the New Shares to the premium listing segment of the Official List of the Financial Conduct Authority and to London Stock Exchange plc for admission to trading of the New Shares on its main market for listed securities (together, "Admission"). The Admission is expected to take place at 8.00 a.m. on Friday 24 March 2023.
Following admission of the New Shares, the Company will have 134,034,491 Ordinary Shares of 5p each in issue. There are no shares held in treasury. Therefore, following admission of the New Shares, the total number of voting rights in the Company will be 134,034,491 (the "Voting Rights Figure"), and this Voting Rights Figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their voting rights interest, or a change to that interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
Diploma PLC | Tel: +44 (0)20 7549 5700 |
John Morrison, Group Company Secretary | |
LEI: 2138008OGI7VYG8FGR19
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.